Stem cell therapy for inflammatory bowel disease

Clinical and Translational Gastroenterology

Volumn 8, Issue 3, 2017, Pages

  Lightner, Amy L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CLINICAL EFFECTIVENESS; CROHN DISEASE; EXPERIMENTAL COLITIS; HUMAN; IMMUNOMODULATION; INTESTINE; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; ULCERATIVE COLITIS;

EID: 85038916462     PISSN: None     EISSN: 2155384X     Source Type: Journal    
DOI: 10.1038/ctg.2017.7     Document Type: Article

References (8)

1. Peyrin-Biroulet L, Harmsen WS, Tremaine WJ et al. Surgery in a population-based cohort of Crohn's disease from Olmsted County, Minnesota (1970-2004). Am J Gastroenterol 2012; 107: 1693-1701.
2. Targownik LE, Singh H, Nugent Z et al. The epidemiology of colectomy in ulcerative colitis: results from a population-based cohort. Am J Gastroenterol 2012; 107: 1228-1235.
3. Mayne CG, Williams CB. Induced and natural regulatory T cells in the development of inflammatory bowel disease. Inflamm Bowel Dis 2013; 19: 1772-1788.
4. Himmel ME, Yao Y, Orban PC et al. Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers. Immunology 2012; 136: 115-122.
5. Melief SM, Schrama E, Brugman MH et al. Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages. Stem Cells 2013; 31: 1980-1991.
6. Khalil PN, Weiler V, Nelson PJ et al. Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease. Gastroenterology 2007; 132: 944-954.
7. Francois S, Bensidhoum M, Mouiseddine M et al. Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: A study of their quantitative distribution after irradiation damage. Stem Cells 2006; 24: 1020-1029.
8. Gonzalez MA, Gonzalez-Rey E, Rico L et al. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 2009; 136: 978-989.